2026 ACGT Investigator Award in Cell and Gene Therapy for Solid Tumor Cancers

2026 ACGT Investigator Award in Cell and Gene Therapy for Solid Tumor Cancers

Funder: Alliance for Cancer Gene Therapy, Inc. (ACGT)

Focus Areas: Translational cell and gene therapy research specifically in solid tumor cancers

Geographic Scope: Research must be conducted at academic medical centers or research centers located in the United States or Canada

Award Amount: $250,000 to $500,000 over two to three years, inclusive of a maximum of 10% indirect costs

Eligible Use of Funds:

Salary

Technical assistance

Supplies

Animals

Capital equipment (not allowed in final year)

May NOT support staff not directly related to the project (e.g., secretaries, administrative assistants)

Eligibility Requirements

• Applicants must hold an MD, PhD, or equivalent degree
• Must be tenure-track or tenured faculty
• Investigator must be conducting original research as an independent faculty member
• No citizenship restrictions (but research location requirement applies)
• Research must be conducted at academic medical centers or research centers in the United States or Canada

Review Process

• Members of the distinguished Scientific Advisory Council oversee review and recommendation
• All Letters of Intent (LOIs) are assessed by at least two Council members or their approved reviewers
• Applicants whose LOIs are responsive to the RFA and mission are invited to submit full applications
• Full applications reviewed carefully by the Council for final approval recommendations

Contact Information

Mailing List: Join the mailing list to receive updates about upcoming Requests for Applications

Organization: Alliance for Cancer Gene Therapy, Inc., a 501(c)(3) organization
Phone: (203) 358-5055
Email: info@acgtfoundation.org
Website: acgtfoundation.org